Harvard geneticist David Sinclair’s seductive notion that aging is a treatable disease has helped companies he founded to raise more than $1 billion. The investors have almost nothing to show for it.
Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Local researchers including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results